Brca2 (XRCC11) deficiency results in enhanced mutagenesis
- PMID: 14614187
- DOI: 10.1093/mutage/geg032
Brca2 (XRCC11) deficiency results in enhanced mutagenesis
Abstract
Brca2 deficiency is associated with chromosomal instability and an increased risk of breast and other cancers. To examine the effect of Brca2 deficiency on mutagenesis, we measured the spontaneous mutation rate at the endogenous hprt gene in the Brca2-deficient Chinese hamster cell mutant V-C8. A 4.3-fold increase was found in the spontaneous mutation rate at this locus, indicating the importance of Brca2 in the prevention of mutagenesis. In addition, following exposure to IR, a 2.3-fold increase in mutant frequency per Gy was found for V-C8 in comparison with wild-type V79. These data suggest a potential risk from ionizing radiation for BRCA2 patients.
Similar articles
-
Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions.Mol Cell Biol. 2002 Jan;22(2):669-79. doi: 10.1128/MCB.22.2.669-679.2002. Mol Cell Biol. 2002. PMID: 11756561 Free PMC article.
-
The Effect of Green and Black Tea Polyphenols on BRCA2 Deficient Chinese Hamster Cells by Synthetic Lethality through PARP Inhibition.Int J Mol Sci. 2019 Mar 14;20(6):1274. doi: 10.3390/ijms20061274. Int J Mol Sci. 2019. PMID: 30875717 Free PMC article.
-
Spectrum of spontaneously occurring mutations in the HPRT gene of the Chinese hamster V79 cell mutant V-H4, which is homologous to Fanconi anemia group A.Mutagenesis. 1996 Mar;11(2):155-9. doi: 10.1093/mutage/11.2.155. Mutagenesis. 1996. PMID: 8671732
-
The Fanconi anemia pathway limits the severity of mutagenesis.DNA Repair (Amst). 2006 Aug 13;5(8):875-84. doi: 10.1016/j.dnarep.2006.05.039. Epub 2006 Jul 11. DNA Repair (Amst). 2006. PMID: 16815103 Review.
-
Evidence for a role for genomic instability in radiation-induced mutagenesis.Radiat Oncol Investig. 1997;5(3):119-23. doi: 10.1002/(sici)1520-6823(1997)5:3<119::aid-roi7>3.0.co;2-0. Radiat Oncol Investig. 1997. PMID: 9303068 Review. No abstract available.
Cited by
-
Zebrafish Xenografts Unveil Sensitivity to Olaparib beyond BRCA Status.Cancers (Basel). 2020 Jul 2;12(7):1769. doi: 10.3390/cancers12071769. Cancers (Basel). 2020. PMID: 32630796 Free PMC article.
-
Enhancement of synthetic lethality via combinations of ABT-888, a PARP inhibitor, and carboplatin in vitro and in vivo using BRCA1 and BRCA2 isogenic models.Mol Cancer Ther. 2012 Sep;11(9):1948-58. doi: 10.1158/1535-7163.MCT-11-0597. Epub 2012 Jul 9. Mol Cancer Ther. 2012. PMID: 22778154 Free PMC article.
-
Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines.Br J Cancer. 2011 Jul 26;105(3):372-81. doi: 10.1038/bjc.2011.243. Epub 2011 Jul 5. Br J Cancer. 2011. PMID: 21730979 Free PMC article.
-
6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.Cancer Res. 2010 Aug 1;70(15):6268-76. doi: 10.1158/0008-5472.CAN-09-3416. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631063 Free PMC article.
-
Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis.Nucleic Acids Res. 2007;35(11):3733-40. doi: 10.1093/nar/gkm315. Epub 2007 May 21. Nucleic Acids Res. 2007. PMID: 17517774 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous